Cargando…
Can the COVID-19 Pandemic Disrupt the Current Drug Development Practices?
Therapeutics and vaccines against the COVID-19 pandemic need to be developed rapidly and efficiently, given its severity. To maximize the efficiency and productivity of drug development, the world has adopted disruptive technologies and approaches in various drug development areas. Telehealth, chara...
Autores principales: | Won, Jung-Hyun, Lee, Howard |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8196831/ https://www.ncbi.nlm.nih.gov/pubmed/34064287 http://dx.doi.org/10.3390/ijms22115457 |
Ejemplares similares
-
The Current Status of Drug Repositioning and Vaccine Developments for the COVID-19 Pandemic
por: Won, Jung-Hyun, et al.
Publicado: (2020) -
Drug-Induced Apoptosis: Mechanism by which Alcohol and Many Other Drugs can Disrupt Brain Development
por: Creeley, Catherine E., et al.
Publicado: (2013) -
Magnitude and causes of routine immunization disruptions during COVID-19 pandemic in developing countries
por: Sharma, Mohit, et al.
Publicado: (2021) -
COVID-19 Pandemic Disruption on the Management of Tuberculosis Treatment in Indonesia
por: Caren, Gabriella J, et al.
Publicado: (2022) -
Surgical Practice in the Current COVID-19 Pandemic: A Rapid Systematic Review
por: Hojaij, Flávio Carneiro, et al.
Publicado: (2020)